Cost of care and treatment and care for people with Alzheimer's disease - the situation in the Czech republic in an international context
Abstract
At present about 37 million people are suffering from Alzheimer's disease worldwide. In Europe it is more than 9 million people and in the Czech Republic roughly 143,000 people.
This fact is connected with the issue of financial means on patients' medications and care.The purpose of this article is to analyze financial demands on care about the people suffering from Alzheimer's disease with special focus on the Czech Republic. In addition, the authors aim to conduct comparison of costs and provision of the treatment in the selected EU countries.
The data about the costs of care and treatment were collected from the publically available databases (Eurostat, OECD, ÚZIS) by using a method of literature search. The costs were divided into direct and indirect, but only the direct costs are analyzed and described in more detail.The authors discovered that in the Czech Republic the costs were spent at most on the persons in the third and fourth stages of Alzheimer's disease.
Furthermore, it is also possible to observe an increasing number of registered patients in group G30.1 - Alzheimer's disease with later onset. With respect to experts' estimates which show provision of care to only 9.5% of people suffering from dementia,an increase in health and social expenditure in the following years can be expected.